Figure 2From: Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primaryIHC results for patient # 12432 (Case report 1). Results of further IHC performed for patient #12432 following the 64 microRNA assay results: A Calretinin X400, B Mesothelin X400Back to article page